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Abstract 
Purpose: To identify the main components of the essential oil (EO) of Baccharis trimera Less and 
investigate their in vitro antifungal activity against seven fungal strains that cause onychomycosis.  
Methods: The chemical composition of EO was determined using gas chromatography, and its 
minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and antifungal 
activity were compared with those of terbinafine and ketoconazole. Scanning electron microscopy 
(SEM) was used to investigate morphological changes in the strains of interest.  
Results: Twenty compounds, with β-pinene being the major constituent (23.4 %), were identified in EO. 
EO exhibited fungicide potential, with MFC values in the range of 0.06 to 125 µg mL−1, which were lower 
than those of the reference drugs against Trichophyton rubrum CCT 5507 URM1666 and Microsporum 
canis ATCC 32903. MIC range for the compounds was from 0.03 to 125 µg mL−1 for five strains of the 
fungi evaluated. For Trichophyton mentagrophytes ATCC 11481 and Epidermophyton floccosum CCF-
IOC 3757, MIC was ≥ 1000 µg mL−1. Flattening, distortions, and shrinkage were observed in the SEM 
images of structures of the five fungal species that were subjected to the action of the EO.  
Conclusion: The results indicate that EO has antifungal activity against filamentous fungi and may be 
developed as an alternative for the treatment of onychomycosis. 
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Mycosis represents an important public health 
concern and its incidence has been increasing in 
recent years, being a frequent cause of visits to 
dermatologists [1]. This increase has numerous 
causes such as susceptible population, 
immunocompromised individuals, fact associated 
with the practice of sports, wearing shoes with 
poor ventilation, use of public pools, and 
manicure instruments [2,3].  
Among the various types of fungal infections that 
affect humans, onychomycosis is caused by 
dermatophytes, yeasts, and non-dermatophyte 
filamentous fungi, and constitutes a major cause 
of nail disease worldwide [4-9]. Species most 
commonly isolated from patients with 
onychomycosis around the world are the 
dermatophytes, Trichophyton rubrum, 
Trichophyton mentagrophytes, Microsporum 
canis, Microsporum gypseum, and 
Epidermophyton floccosum [2,5,10,11].  
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Treatment of onychomycosis is still considered a 
challenge owing to the anatomical characteristic 
of the nail substrate, chronicity of the disease, 
and relapse cases [12]. Many antifungal drugs 
available in the market are not effective either 
because of their improper use or due to the 
development of resistance mechanisms of the 
fungus [13,14]. 
 
In this context, many studies have been carried 
out in search of new antimicrobial products, 
including products that make use of medicinal 
plants [12,15-18], such as Baccharis trimera 
Less (DC) [19,20]. Being a part of the 
Asteraceae family [21,22], B. trimera has 
numerous pharmacological activities popularly 
attributed to their leaves, such as anti-
inflammatory, digestive [23], antioxidant [24], 
antiulcer [23,25], and antimicrobial [19,20] 
properties that can be helpful in the treatment of 
diabetes [26], rheumatism, and hepatobiliary 
disorders [27]. Therefore, the aim of this study 
was to investigate the in vitro antifungal activity 
of the essential oil of B. trimera against the main 





B. trimera essential oil  
 
The essential oil of the leaves of B. trimera (lot 
BATRI0111), which was extracted by vapor 
entrainment, was obtained from Laszlo 
Aromatology Company LTDA, Brazil. 
 
Gas chromatography  
 
To qualitatively and quantitatively characterize 
the main chemical constituents of this essential 
oil, an aliquot (50 µL) of oil was subjected to 
high-resolution gas chromatography (HP 5890) 
equipped with flame ionization detector. A BP-1 
(SGE) 25 m × 0.25 mm column was used, with a 
temperature gradient of 60 °C/min and 3 °C/min 
to 220 °C, along with an injector (split of 1/50) at 
220 °C and detector at 220 °C. The carrier gas 
used was hydrogen (2 mL/min) and the injection 
volume was 1 µL. The samples were diluted to 
0.5 % in chloroform. Characterization of the 
peaks was performed by calculating the Kovats 
retention index and compared with the literature 
data [28]. 
 
Fungal strains  
 
Standard strains of filamentous dermatophytes 
from the Collection of Tropical Crops (CCT) were 
provided by Foundation André Tosello, 
Campinas, SP, Brazil (Trichophyton rubrum 
CCT-5507 URM 1666) and American Type 
Culture Collection (ATCC) provided by the 
National Institute of Quality Control in Health, 
Oswaldo Cruz Foundation, Rio de Janeiro, RJ, 
Brazil (T. mentagrophytes ATCC 9533, T. 
mentagrophytes ATCC 11480, and T. 
mentagrophytes ATCC 11481, M. gypseum 
ATCC 14683, M. canis ATCC 32903 and E. 
floccosum CCF-IOC 3757). 
 
Microbiological screening  
 
Microbiological screening was performed 
according to the technique described by Souza 
et al [29] by using sterile 24-well plates (Sarstedt, 
Germany). A 2 mm fungal fragment was 
inoculated onto a plate containing Sabouraud 
dextrose agar (SDA) with the essential oil of B. 
trimera (1,000 µg mL-1 β-pinene). Likewise, a 
positive control (SDA with fungal fragment in the 
absence of essential oil) and negative control 
(SDA with essential oil in the absence of fungal 
fragment) were prepared. Subsequently, the 
plates were incubated at 28 °C ± 2 °C for 7 days.  
 
Determination of minimum inhibitory 
concentration (MIC)  
 
The MIC was determined for the essential oil of 
B. trimera according to the protocol M38-A of 
The National Committee for Clinical Laboratory 
Standards (CLSI) [30], adapted as required by 
Almeida et al [31]. All analyses were performed 
in triplicates. 
 
For the preparation of the fungal suspension, 
fungal cultures obtained after 7 days of 
incubation in tubes with slanted SDA were used. 
The cultures were washed thrice by adding 2 mL 
of 0.85 % sterile saline and 20 µL of Tween-80 
solution/dimethyl sulfoxide analytical grade (1: 1, 
v/v). The suspension formed [30] was analyzed 
by employing a spectrophotometer (Libra S12, 
Biochrom, UK) using quartz cuvette with an 
optical path of 1.0 cm and the transmittance was 
adjusted in the range of 68 – 70 % at a fixed 
wavelength of 530 nm [31]. The suspension was 
subsequently diluted at a ratio of 1: 50 (v/v) with 
RPMI-1640 medium (Sigma, USA) buffered with 
3 (N-morpholino) propanesulfonic acid (MOPS, 
JTBaker, Germany). A 100 µL aliquot of this final 
solution was transferred to the microtiter plate 
and used for MIC determination. 
 
The reference drugs terbinafine and 
ketoconazole were evaluated at concentrations 
from 0.0234 to 12 µg mL−1 and 0.0313 to 16 µg 
mL−1, respectively, in RPMI-1640 buffered with 
MOPS [30-31]. Dimethyl sulfoxide analytical 
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grade (Sigma, Brazil) was used for the 
solubilization of the reference drugs [30]. 
 
The essential oil of B. trimera was solubilized in 
RPMI-1640 buffered with MOPS and evaluated 
at eight concentrations in the range from 7.8 to 
1,000 µg mL−1 of β-pinene. Subsequently, 100 
µL of each dilution of terbinafine, ketoconazole, 
and essential oil were transferred to the 96-well 
microplate. The fungal viability test was 
performed by adding 200 µL of RPMI-1640 
buffered with MOPS containing the fungal 
inoculum. After these steps, the culture was 
homogenized for 2 min and incubated at 28 °C ± 
2°C for 7 days. 
 
Minimum fungicidal concentration (MFC)  
 
After the determination of MIC, MFC was 
determined according to Magagnin et al [32]. 
Aliquots of 10 µL of the medium without fungal 
growth were transferred to new 96-well 
microplate containing 200 µL of Sabouraud 
dextrose broth without any antifungals. 
 
Scanning electron microscopy (SEM)  
 
Untreated fungal fragments and fungal fragments 
treated with terbinafine, ketoconazole, or 
essential oil of B. trimera were analyzed by SEM. 
The fungal fragments that were subjected to 
SEM were prepared according to Martinelli and 
Santos [33] and Mio et al [34] using the 
Karnovsky solution (2.5 % glutaraldehyde and 
2.5 % formaldehyde in 0.05 M sodium cacodylate 
buffer and 0.001 M calcium chloride; pH of 7.2) 
for 24 h, a solution of 1 % osmium tetroxide for 1 
h in the dark, and solutions of acetone (25 %, 50 
%, 70 %, 90 %, and 100 %). Subsequently, the 
resulting fragment was fixed on aluminum stubs 
with the aid of a double-sided carbon tape and 
brought to the metallizer (Balzers FL-
9496/Fürstentum Liechtenstein), where they 
were subjected to a gold steam bath for 180 s. 
 
The fungal samples were subjected to scanning 
electron microscope (JSM-5310, JEOL) under 
the conditions of 25-Kv power and working 
distance of 17 mm. The analyzes were 
performed at the Electron Microscopy Center 
Scanning the Federal University of Rio de 
Janeiro and the Department of Physics of the 




The essential oil of B. trimera subjected to gas 
chromatography showed monoterpenes 
carquejyl acetate and β-pinene as the major 
constituents (Figure 1 and Table 1), with β-
pinene exhibiting the highest percentage (23.4 
%). Peaks under 0.1 % were not considered. 
 
Preliminary assay of the fungal fragments 
revealed that T. mentagrophytes ATCC 9533; T. 
mentagrophytes ATCC 11480, T. rubrum CCT 
5507 URM 1666, M. canis ATCC 32903, and M. 
gypseum ATCC 14683 showed no visible fungal 
growth when exposed to B. trimera oil (1,000 µg 
mL-1 β-pinene). However, T. mentagrophytes 
ATCC 11481 and E. floccosum CCF-IOC 3757 
presented some growth. Thus, it was possible to 
observe the respective antifungal activity of the 
essential oil against five strains tested. The MIC 
values for the essential oil of B. trimera and the 
reference drugs (terbinafine and ketoconazole) 




Figure 1: Chromatographic profile of the essential oil of B. trimera.  
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Table 1: Chemical profile of the essential oil of B. trimera 
 
No. Compound % Kovat’s index  
1 α-pinene 2.2 928 
2 Sabinene 0.5 967 
3 β-pinene 23.4 973 
4 Myrcene 0.8 986 
5 Limonene 5.9 1021 
6 E-β-ocimene 0.6 1039 
7 Carquejol 0.4 1150 
8 Neral 2.3 1231 
9 Geranial 4.1 1258 
10 carquejyl acetate 19.0 1295 
11 β-elemene 0.8 1388 

































Total  89.7  
 




Essential oil of 
B. trimera Terbinafine Ketoconazole 
MIC MFC MIC MFC MIC MFC 
T. mentagrophytes ATCC 9533 31.25 62.50 3 3 2 4 
T. mentagrophytes ATCC 11480 125 125 0.03 0.03 1 1 
T. mentagrophytes ATCC 11481 >1,000 NE 0.03 0.03 0.25 0.25 
T. rubrum CCT 5507 URM 1666 0.03 0.06 0.19 0.19 1 4 
M. canis ATCC 32903 0.24 0.98 0.19 0.19 0.06 8.01 
M. gypseum ATCC 14683 125 125 0.12 0.12 8 16 
E. floccosum CCF-IOC 3757 >1,000 NE >480 NE >640 NE 
MIC: Minimum inhibitory concentration; MFC: Minimum fungicidal concentration. *Results expressed as µg mL−1; 
NE: not established (for strains with MIC values above the determined working range) 
 
The electron micrographs of the fungal strains 
(exposed or not exposed to the reference drugs 
and essential oil of interest) are presented in 
Figure 2. 
 
The analysis of electron micrographs allowed us 
to morphologically identify the fungal structures 
and perceive the morphological changes in the 
fragments of T. rubrum CCT 5507 URM 1666, T. 
mentagrophytes ATCC 9533, M. gypseum ATCC 
14683, and M. canis ATCC 32903, which were 
subjected to the essential oil of B. trimera. The 
abnormalities identified suggested the “flattening” 





The constituents considered as chemical 
markers of the essential oil of this species were 
identified as carquejyl acetate and carquejol; 
however, these were present in small 
percentages [19,20]. Nevertheless, the 
percentage of the chemical constituents of the 
essential oil analyzed is different from that 
reported in other works [19,35], It should be 
noted that there are factors related to the 
essential oil can cause changes in its chemical 
composition. These include the time of collection 
and drying of the plant material, soil types, 
genetic factors, climate, and extractive processes 
[36]. 
 
In B. trimera oil, monoterpenes were identified, 
and among them, β-pinene and carquejila 
acetate were found at high levels. This class of 
substances present in the Asteraceae family is 
related to antifungal activity [37], because they 
may increase the concentration of lipid peroxides 
such as hydroxyl, alkoxyl, and alkoperoxyl 
radicals and lead to cell death [36].  
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Figure 2: Electron micrographs of the fragments of T. rubrum CCT 5507 URM 1666 (A), T. mentagrophytes 
ATCC 9533 (B), M. canis ATCC 32903 (C), and M. gypseum ATCC 14683 (D). The magnification of the images 
corresponds to 3,500x, with the exception of images D III, whose magnification is 4,000x. Fungal fragments: not 
exposed to any substance of interest (I), exposed to ketoconazole (II), exposed to terbinafine (III), and exposed 
to the essential oil of B. trimera (IV). “a” indicates hyphae and no changes in tubular appearance. “b” denotes 
hyphae/mycelium puckered and/or compacted. “c” indicates hyphae/mycelium forming a compact mass and/or 
contorted and rough. “d” denotes macroconidia. “e” indicates macroconidia and rough 
 
Therefore, further experiments were developed 
according to the percentage of β-pinene because 
it is the major constituent for this B. trimera oil 
and has been reported to possess antifungal 
activities [35]. It is important to emphasize that 
there is a possibility of synergism between 
different molecules of the essential oil, which 
could be responsible for the pharmacological 
activity [38]. Sharma and Tripathi [39] indicated 
that essential oil acts on the hyphae presumably 
causing leakage of the cytoplasm, less stiffness 
and integrity of the cell wall, and collapse and 
death of the mycelium. In general, essential oil, 
being hydrophobic, could penetrate the 
mitochondrial membrane and cause cell damage, 
allowing easier release of vital cell components, 
besides interfering with the enzymatic and 
cellular respiration system [36]. 
 
It should be noted that the essential oil of B. 
trimera (MFC = 0.06 µg mL−1) was more potent 
than the drugs terbinafine and ketoconazole 
(MFC = 0.19 and 4.00 µg mL−1, respectively) 
against T. rubrum and also exhibited lower value 
of MFC (0.98 µg mL−1) than ketoconazole (8.01 
µg mL−1) against M. canis. In other words, the 
antifungal activity of the essential oil against the 
two fungal strains, T. rubrum and M. canis, was 
higher, when compared with that of 
ketoconazole. These data are in accordance with 
those reported by Rodriguez et al [40], who 
stated that plants of the genus Baccharis L. are 
used in Argentina and other South American 
countries for the treatment of fungal diseases. 
 
Although the MIC values of the essential oil for 
some fungal strains were higher than those of 
terbinafine and ketoconazole, with the increase 
in recurrence, development of fungal resistance, 
and high number of adverse reactions caused by 
the current treatment available, the use of this 
vegetable substance may be an alternative way 
to treat onychomycosis and/or act as an adjuvant 
therapeutic [2]. 
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The electron micrographs of the untreated T. 
mentagrophytes presented tubular form with 
branches, similar to that described by Park et al 
[41], indicating the effect of terpenes on this 
strain. After being exposed to terbinafine, 
ketoconazole, and essential oil of B. trimera, 
distortions and shrinkages in the hyphal 
morphology were observed. Comparison of the 
electron micrographs of the strains exposed to 
essential oil with those not exposed to any 
substance of interest revealed the potential 
damage of the fungal structures, exhibiting 
results similar to those obtained with the 
reference drugs. This finding demonstrated the 





The essential oil of B. trimera has antifungal 
effect against two of the three genera of 
filamentous fungi. Further studies on the safety 
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